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ABSTRACT
Amyotrophic lateral sclerosis is neurodegenerative disease characterized by late-onset,
loss of motor neurons, paralysis, and eventual death. SOD1 is a free radical scavenger that
normally resides in the cytoplasm, nucleus, and intermembrane space of the mitochondria.
Mutations in SOD1, a ubiquitously expressed free-radical scavenger, are one cause of ALS.
Degeneration of motor neurons is thought to be triggered by aggregation of mutant SOD1
followed by propagation to adjacent cells though cell-cell contacts. Here, we present
immunohistochemical findings on tissues of a Drosophila melanogaster expressing mutant
dsod1 alleles at the endogenous locus. Aggregate-specific antibodies were used to assess the
presence of aggregates in salivary gland tissues and the CNS for mutant and wildtype sod1
alleles. Immunocytochemistry revealed the presence of large cytoplasmic aggregates near the
nuclei of larval salivary glands of dsod1G85R/G85R mutants and in the salivary glands and CNS of
dsod1H48R/H48R mutants. Aggregation phenotypes occurred with partial penetrance and penetrance
did not increase with age. Furthermore, because both dsod1G85R/G85R and dsod1H48R/H48R mutants
exhibit lethal phenotypes with complete penetrance, our data suggest a lack of correlation
between the presence of visible aggregates and toxicity.
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Chapter 1

Amyotrophic Lateral Sclerosis and
Protein Aggregation
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AMYOTROPHIC LATERAL SCLEROSIS
Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease
characterized by the loss of motor neurons, paralysis, and death (Haverkamp et al., 1995). The
disease has a three to five-year prognosis, with <20% surviving five years after the initial
symptoms (Grad et al., 2014). Ten percent of cases are familial (fALS) and the remaining 90%
are sporadic (sALS), with unknown origin (Grad et al., 2014). Risk factors for sporadic ALS
include environmental exposures such as BMAA exposure (Bradley & Mash, 2009), nutrition
such as higher consumption of carbohydrates (Okamoto et al., 2007), and trauma such as
repeated head injuries (Chen et al., 2007).
In familial ALS (fALS), inheritance is mostly dominant and monogenic, following a
Mendelian pattern of inheritance (Gros-Louis et al., 2006). Currently, >20 genes have been
identified as causal and the function of these gene products fall into several classes (Chen et al.,
2013). Mutations in RNA processing genes consist of one subset of causal genes. This includes
mutations in the ubiquitinated TAR DNA binding protein (TDP-43), which is normally involved
in RNA splicing (Buratti & Baralle, 2001), gene transcription (Lalmansingh et al., 2011),
microRNA processing and stabilization (Kawahara & Mieda-Sato, 2012), and mRNA transport
(Chu et al., 2019). This also includes the RNA-binding protein FUS (Crozat et al., 1993) which
is linked to ALS due to aberrant RNA processing. Moreover, mutations in genes that cause
axonal transport dysfunction such as DCTN1, a motor protein responsible for ATP hydrolyzation
coupled with cellular motility (Holzbaur & Tokito, 1995), causes some fALS cases. Mutations
the integral ER membrane protein VAPB also causes some fALS cases (Münch et al., 2004;
Nishimura et al., 2004) due to metabolic disturbance in vesicle trafficking (Nishimura et al.,
2004) and lipid transporting (Han et al., 2013).
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The research surrounding other ALS-causing genes suggests disease can result from a
variety of pathways involved in RNA processing, axonal transport, or metabolism for fALS;
however, clear, unequivocal triggers that lead to sALS are still unknown. Much research
therefore focuses on fALS in hopes that we will understand the underlying mechanisms of sALS,
given the overlapping clinical features of the disease. fALS has been modeled in many
genetically tractable systems using a variety of genetic engineering techniques to express
pathogenic fALS alleles for almost all identified genes thus far.
SOD1
A large area of ALS-related research concerns superoxide dismutase 1 (SOD1) which can
cause both fALS and sALS (Cudkowicz et al., 1997). While some SOD1 mutations do not cause
fALS (Mayeux et al., 2003), there is potential for abnormal interactions between mutant SOD1
and a pathway or with itself that can hinder it more susceptible to the development of the
sporadic condition. Also, there is also the possibility that SOD1 mutations occur de novo without
prior family history, resulting in the sporadic condition. Further SOD1 research may bridge the
understanding between the familial and sporadic conditions. Disease alleles in SOD1 were first
linked to ALS patients through work done by Rosen et al. (1993). In fALS, more than 170-point
mutations in SOD1 (Sangwan et al., 2017) account for ~20% of all fALS cases (Pasinelli &
Brown, 2006). Most of the disease-causing mutations of SOD1 are in exon coding regions,
suggesting aberrant protein function rather than levels of expression are associated with disease.
Superoxide dismutase 1 (SOD1) is a ubiquitously expressed homodimer and each subunit
has copper and zinc atom binding sites. The SOD1 gene is also highly conserved across different
species suggesting it has a crucial role in cellular function (Fridovich et al., 1995). In the cell,
SOD1 converts superoxide anions to hydrogen peroxide, which is then converted to water and
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oxygen enzymatically by catalase. This enzymatic activity is essential for reducing oxidative
damage as a result of aerobic metabolism in cells. SOD1 is located within the cytoplasm,
nucleus, and intermembrane space of the mitochondria to protect against oxidative damage
(Sturtz et al., 2001), suggesting that loss of enzyme function consequently leads to oxidative
stress.
Gain or loss of function. Although the enzymatic activity of wildtype SOD1 plays a
protective role against oxidative stress, research suggests that ALS-causing mutations result in
misfolding of the enzyme creating a range of allele-specific enzymatic activity patterns.
In the human disease, most SOD1 mutations are dominant, suggesting a gain of function which
has been identified as the propensity of the protein to form toxic aggregates. Yet, there is a
decrease in enzymatic activity for almost all mutant alleles, suggesting a loss of function. Based
on red blood cell data from human ALS patients, 48 different SOD1 mutants showed an overall
reduction of SOD1 activity that averaged 58% (Saccon et al., 2013). It is still debated whether
mutated SOD1 results in a gain of function or loss of function disease. The consensus is that
there is a gain of function component because all SOD1 fALS mouse models exhibit SOD1
aggregation, while SOD1 knockout mice do not develop classical ALS, although they do show
some motor neuron pathology (Reaume et al., 1996). These data could suggest that SOD1 is not
essential to the development of motor neurons, but SOD1-deficiencies increases the likelihood of
motor neuron injury over time (Reaume et al., 1996). Thus, some scientists believe that
mutations in sod1 cause fALS by both a gain and loss of function.
Animal Models of ALS
It is critical that researchers have the appropriate disease model to study ALS. It is
important for animal models to not only express disease alleles but that the phenotypes
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recapitulate disease features. Specifically, for ALS, an animal model should display adult-onset,
neurodegeneration, and lethality. Models of fALS can help determine whether SOD1 mutants are
gain or loss of function alleles and whether that information can be translated to human
therapeutics. If fALS caused by SOD1 mutations results from a loss of enzyme activity, freeradical scavengers or antioxidant therapies may hold potential value in humans. If the disease
state results primarily from gain of function, then therapeutics which eliminate protein
aggregates may hold potential value. Valid animal models can serve to assess the potential for
new drugs.
Over the years, researchers have developed different SOD1 models that phenotypically
display ALS-related symptoms. To achieve the diseased state, researchers have developed
transgenic models with the goal of reproducing ALS-associated phenotypes. Whereas human
fALS follows a dominant monogenic pattern of inheritance, engineered mouse models rely on
multiple copies of an inserted hSOD1 transgene to reproduce ALS-like phenotypes. This is true
for both wildtype and mutant models. For example, one wildtype transgenic mouse expressed
10.5 copies of the transgene (Wong et al., 1995). Overexpression of wildtype humanized SOD1
has been shown to reproduce some disease features such as mitochondrial swelling in spinal cord
axons, axonal degeneration, mild motor neuron death, and motor abnormalities (Jaarsma et al.,
2000). Similarly, mutant copy can vary from as much as 10 (Gurney et al., 1997) to 18 (Gurney
et al., 1994) copies and this also negatively affects survival. With an increasing copy number of
the G93A transgene from 4 to 34, survival went from 625.0 to 99.0 days (Alexander et al., 2004).
Accelerated disease onset was also shown in mice overexpressing G85R (Wang et al., 2009).
Although wildtype and mutant studies of overexpression have provided useful
information about the mechanisms underlying ALS, it is unclear how relatable the results of
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these transgenic mice models are to the human disease. Expression of endogenous mutant SOD1
in fALS in humans leads to neurodegeneration while not requiring overexpression (Ferrera et al.,
2003). No model organism can mimic every aspect of the human disease, but most models do
replicate one trademark of ALS seen in humans based on postmortem examination: protein
aggregates.
SOD1 Aggregates
Protein aggregates are a characteristic hallmark of ALS pathology and are found in the
spinal cord samples of fALS (Johnston et al., 2000; Gruzman et al., 2007) and sALS patients
(Shibata et al., 1994). Researchers have developed various procedures to detect the presence of
aggregates in cells, and specifically, to detect the presence of SOD1 in aggregates.
Detecting Protein Aggregates. One method is size-exclusion chromatography, which separates
molecules based on size using gel filtration (Martins & English, 2014). This method effectively
separates lower molecular weight soluble proteins from large molecular weight, insoluble
aggregates. Another example comes from the quantification of aggregates formed by dosedependent protease inhibition (Lee et al., 2017). Detergent extractions can also be used to detect
aggregates. In this procedure, protein is separated into soluble and insoluble fractions, where
higher molecular aggregates will be present in the insoluble portion (Prudencio & Borchelt,
2011). Also, fluorescent microscopy has been used to detect SOD1 fused to fluorescent proteins
in cell culture or in vivo (Álvarez-Zaldiernas et al., 2016).
As a related technique, antibodies which specifically recognize aggregated protein can be
utilized. Immunoblotting with an anti-SOD1 antibodies has detected the presence of SOD1
aggregates in various assays (Bruijn et al., 1997; Wang et al., 2009; Afshar et al., 2017). Bergh et
al. (2015) developed polyclonal mono-specific antibodies that recognized specific residues on
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wildtype and misfolded humanized SOD1 in mice. The researchers discovered that the antibody
raised against the conformationally hidden 57-72 epitope recognized a misfolded state of human
SOD1 when expressed in mouse models and in post-mortem tissue. The antibody raised against
the 111-127 SOD1 epitope recognized a mostly hidden structure in the protein and was found to
detect aggregates as well, although evidence suggests that this latter antibody recognizes a
different misfolded state. Both epitopes are good antibody recognition candidates for the
detection of misfolded SOD1 and suggest that the protein can take on multiple independent
aggregate conformations.
Formation of Misfolded SOD1 Inclusions. Properly detecting SOD1 in ALS models has
provided and will continue to provide important information on the molecular and cellular
behaviors of SOD1 under different conditions. Relevant to the present study, SOD1 aggregate
detection and characterization can provide useful information regarding its role in disease.
Evidence suggests that SOD1 can take on prion-like properties when misfolded. Prions are
proteins with strong, covalently linked beta-pleated sheets which can propagate the misfolding of
more protein (Pan et al., 1993). Prion diseases begin with a primary prion protein that interacts
with other natively folded protein of the same kind to promote misfolding and beta-pleated sheet
formation (Geschwind, 2015). Prions continue to convert more protein exponentially,
accumulate, and can migrate between cells through release in the extra-cellular matrix and
through gap junctions. It is unknown if the prion induces the accumulation or if some
unidentified intermediate structure is responsible for promoting conversion (Geschwind, 2015).
One route of protein misfolding and aggregation comes from post-translational studies of
SOD1. Mutant and oxidized SOD1 also display the ability to sequester and promote aggregation
(McAlary et al., 2016; Martins & English, 2014). The kinetics of post-translational modification
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is critical to proper protein folding and maturation (Bruns & Kopito, 2007). This can include the
binding of the zinc atom, which is suggested to be important for stabilization of the protein (Sea
et al., 2015). Also, mutations in the copper binding region slow kinetic rates of dimerization and
disulfide bond oxidation (Bruns & Kopito, 2007). Problems in post-translational modifications
can therefore result in aberrant SOD1 protein.
Destabilization of native SOD1 structure due to mutations such as A4V effected dimer
interactions and subunit misfolding (Deng et al., 1993). Also, destabilization of the protein is
associated with the ability to form aggregates and induce cell toxicity (McAlary et al., 2016).
Mutant SOD1 can adopt several conformations that are more susceptible to aggregation and
higher order filaments. As SOD1 misfolds, hydrogen bonds become more established between
the beta strands and amyloid-like structures form as a direct result of mutated SOD1 (Banci et
al., 2008). Similarly, metal-binding deficient human SOD1 misfolded to create filaments that
interacted and promoted the assembly of higher order filaments (Elam et al., 2003).
Aggregates are a common phenotype amongst post-mortem fALS (Johnston et al., 2000),
sALS (Shibata et al., 1996; Paré et al., 2018), and mice ALS spinal cord samples (Bergh et al.,
2015). Mutations in other ALS-causing genes also produce protein aggregates (Neumann et al.,
2006; Deng et al., 2010; Deng et al., 2011). These high molecular weight inclusions consist of
misfolded protein and their penetrance in causal-ALS suggests toxic properties, based on
ubiquitination and autophagy activation.
Aggregate toxicity. Exactly how aggregated proteins are toxic to cells is not yet fully
understood. Ubiquitination is a part of a major degradation pathway called the ubiquitin
proteasome system (Ramesh & Pandey, 2017) and ubiquitinated inclusions are present in both
fALS and sALS (Leigh et al., 1991; Mather et al., 1993), which suggests the activation of this
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degradation system. There was an accumulation of inclusions in the astrocytes of human G85R
mice as the disease progressed, and these inclusions were immunoreactive for ubiquitin (Bruijn
et al., 1997). Similar to mutants, oxidized wildtype SOD1 was poly-ubiquitinated (Ezzi et al.,
2007), therefore suggesting that degradation cascades are activated in the presence of mutant and
oxidized wildtype SOD1.
Autophagy, which is another major protein degradation pathway, is also activated in ALS
(Ramesh & Pandey, 2017). A common autophagy marker was used to detect the activation of
autophagy degradation in transgenic SOD1G93A mice (Xie et al., 2015). Deficiencies in key
players of the autophagy pathway result in early onset of ALS (Tokuda et al., 2016) and
exacerbated aggregation (Nassif et al., 2014), indicating its crucial role in the removal of these
toxic elements. The importance of autophagy was also demonstrated in a food restriction diets of
mice (Zhang et al., 2013). Food restriction induced autophagy and when restriction was
implemented at the onset of disease rather than at a later stage, it had a favorable impact on
SOD1G93A mice.
Cells attempted to eliminate protein aggregates based on the induction of protein
degradation pathways, but when cells are unsuccessful, the most evident consequence is death.
For instance, cultured motor neurons that uptake SOD1-positive aggregates were selectively
killed (Benkler et al., 2018). The formation of aggregates was associated with reduced cell
survival in cells expressing mutant SOD1 (Matsumoto et al., 2005). Aggregates may be the result
of unsuccessful protein degradation attempts, and therefore it is important to further characterize
their role in disease.
It is worth noting that high-molecular weight aggregates have catalytically inactive
SOD1, whereas low-molecular weight aggregates have catalytically active SOD1 (Martins &
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English, 2014), suggesting a toxic intermediate. The properties of soluble SOD1 intermediates
correlate with the properties of toxic prion-like intermediates that propagate misfolding.
SOD1 Prion-like Intermediate. SOD1 monomers have properties that can promote the
formation of higher order structures. In vitro, oxidatively damaged wildtype and mutant SOD1
dissociated into their monomers and slight changes to the secondary and tertiary structure of the
protein promoted aggregation (Rakhit et al., 2004; Khare et al., 2004). The inactive monomer
could be the intermediate that induces misfolding and aggregation. Similarly, SOD1 mutants
with specifically exposed hydrophobic sequences have the potential to induce aggregation
(Münch & Bertolotti, 2010).
The activity of these toxic intermediates may be due to deficiencies in metal binding of
SOD1. Reduced monomeric forms of mutant SOD1, which tend to have more prominent metal
binding mutations, are more susceptible to oligomerization by the oxidization of free cysteines
(Banci et al., 2007). Inadequate folding of SOD1 due to delays in post-translational folding
kinetics can result in the failure to incorporate metal cofactors important for stability and
function (Bruns & Kopito, 2007).
These toxic intermediates result in aberrant behaviors. For example, SOD1 was found to
only interact with a specific neurosecretory protein when mutated but the oxidized form also
bound the protein, suggesting that oxidized SOD1 developed a mutant-like property (Ezzi et al.,
2007). Also, oxidized wildtype SOD1 induced inflammatory pathways in cultured motor neurons
(Ezzi et al., 2007).
While research points towards a toxic intermediate that mitigates aggregation, another
prion-like property of SOD1 exits. Evidence suggests that like prions, SOD1 can be released to
the surrounding environment and mitigate aggregation of proteins in other cells.
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Extracellular vesicles. SOD1 displays the ability to spread itself intercellularly by extracellular
vesicles (Grad et al., 2014). Evidence suggests that mutant SOD1 expressed in astrocytes had
increased unconventional secretory pathways, which included the release of SOD1 by exosomes
(Basso et al., 2013). The increased activity could be a protective response to decrease the amount
of mutant protein in the cell, as an attempt to prevent aggregate formation. Moreover, wildtype
and mutant SOD1 were secreted from motor neuron-like cells through exosomes (Gomes et al.,
2007).
Research suggests that cells release aggregates into the extracellular environment through
exosomes and it was observed that nearby healthy cells were infected (Fevrier et al., 2004),
suggesting progressive spread. Hence, the release and spread of misfolded SOD1 from cell to
cell by exosomes may explain how the sporadic condition progresses without the presence of a
causal genetic component (Grad et al., 2014). Though misfolded SOD1 is observed in the
inclusions of fALS models, the presence of SOD1 positive inclusions is still highly debated in
the field.
sALS and Aggregates. Determining whether protein aggregates are pathologic in sporadic cases
of ALS is still unknown and debated. SOD1-containing inclusion have been extracted from
SOD1-linked sALS patient spinal cord tissue, suggesting that the wildtype protein can exert
similar effects as mutant SOD1 (Gruzman et al., 2007; Forsberg et al., 2010). While some
research groups have evidence to suggests the presence of misfolded SOD1 in post-mortem
sALS patients (Paré et al., 2018; Bosco et al., 2010; Forsberg et al., 2010), others find no
evidence of misfolded SOD1 (Liu et al., 2009; Kerman et al., 2010) or find no difference
between controls and sALS patients (Da Cruz et al., 2017).
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One group found cytoplasmic misfolded SOD1 in the spinal cord of post-mortem sALS
patients using four different polyclonal antibodies and one monoclonal antibody that recognized
different epitopes of SOD1 and were also able to immunocapture misfolded SOD1 (Paré et al.,
2018). The immunohistochemical staining suggested that SOD1 can take on different
conformations when misfolding. Paré and colleagues (2018) argued that differences in
methodology such as antibody concentration or buffer choices may be the reasons why some
researchers do not find misfolded SOD1 in sALS cases. Regardless of the debate, there are
countless studies that have found SOD1-positive inclusion in human sALS spinal cords (Shibata
et al., 1994; Matsumoto et al., 1996), suggesting that SOD1 plays a role in aggregate production
or degradation.
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Chapter 2

Detecting Protein Aggregation Using
Aggregate-Specific Antibodies in a Drosophila
Melanogaster Model of Amyotrophic Lateral Sclerosis
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INTRODUCTION
Drosophila melanogaster as a model of ALS
To understand the underlying roles of SOD1 in aggregate production, it is critical to use a
proper model organism that displays the characteristics of the human disease. Though most of
the ALS-model organism research comes from mice studies, there are downsides to this model.
In mice, fALS is modeled by overexpressing mutant human sod1 alleles. This occurs in a genetic
background containing endogenous wildtype SOD1 orthologs. Thus, the genetics of the mouse
ALS model is quite different from the human state in which a single mutant allele is sufficient to
produce disease phenotypes.
Drosophila melanogaster was first used a model system in 1910 by the Morgan lab at
Columbia University (Morgan, 1910). Since then, it has become a useful scientific tool to study
the genetics of disease and neurodegeneration. Drosophila are also inexpensive to maintain, mate
quickly, and have shorter lifespans than larger model systems. This allows for more and faster
results. Drosophila genetics can be easily manipulated to express certain genes in a tissuespecific or dosage-specific manner. Moreover, the entirely sequenced genome of Drosophila was
available in 2000 (Adams et al., 2000), expanding the incite of genetic associations on disease.
Drosophila has also been used as a model for other neurodegenerative diseases, such as
Parkinson’s (Lee et al., 2007), tauopathies (Blard et al., 2007), and polyglutamine expansion
diseases (Jackson et al., 1998). In the context of SOD1-ALS, Drosophila is a great organism to
recapitulate the human disease, as they have a simpler nervous system and reproduce ALS-like
phenotypes such as SOD1-positive aggregates (Bruijn et al., 1997), motor dysfunction (Held et
al., 2019), mitochondrial dysfunction (Gallart-Palau et al., 2016), and decreased lifespan (Şahin
et al., 2017).
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Creating an ALS model by homologous recombination. To create a model which does not
rely on SOD1 overexpression, Şahin and colleagues (2017) knocked in wildtype and mutant
Drosophila sod1 (dsod1) into the endogenous locus of the Drosophila genome using ends-out
homologous recombination. This fALS model successfully displayed typical human ALS
phenotypes such as reduced lifespan and decreased motor function; however, all these
phenotypes were recessive unlike the human disease. Interestingly, fly models containing 4
copies of sod1 (sod1G85R/G85R; sod1+/+) show phenotypes similar to mouse models and are the
closest to the mouse genotypes used to recreate disease features.
Purpose of research. To detect dSOD1 aggregation in ALS, I used immunocytochemistry to
visualize wildtype and mutant dSOD1 protein in the salivary glands and CNS of a Drosophila
melanogaster model of ALS made by homologous recombination. These tissues were chosen
because the salivary glands of larvae are useful to detecting protein due to their large cell size
and polytene nuclei. Moreover, using adult tissue can be more beneficial at tracking disease
progression with age. The CNS was used because ALS is a neurodegenerative disease and latestage phenotypes of fALS and sALS include protein aggregates in the spinal cord samples of
patients (Gruzman et al., 2007). Therefore, evidence of mutant SOD1-positive aggregates in the
Drosophila CNS would suggest that SOD1 accumulation is not unique to the human disease and
strengthens the argument that SOD1 can play a role in aggregate formation. My results show that
mutants dsod1G85R/G85R and dsod1H48R/H48R displayed mutant-specific aggregation phenotypes at
partial penetrance in salivary glands which was not age-dependent and dsod1H48R/H48R VNC
samples displayed large cytoplasmic aggregates that colocalized with the nucleus at partial
penetrance. Also, smaller salivary glands and increase misfolded dSOD1 staining was caused by
knockdown of ebp1, a known enhancer of heterozygous dsod1G85R/+ flies. These results suggest
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that dSOD1 protein can adopt various conformations, and that aggregates do not completely
correlate with lethality.
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MATERIALS and METHODS
Drosophila melanogaster stocks
Ends-out homologous recombination (HR) was used to create the dsod1WTLoxP (dsod1+)
dsod1G85R, dsod1H48R, and dsod1H71Y stocks as previously described (gift from the Reenan lab,
Brown University) (Şahin et al., 2017). All mutant alleles were maintained as heterozygous
stocks over 3rd chromosome balancers. CRISPR/Cas9 was used to create the dsod1-/- and
hsod1m1m5 stocks as previously described (Şahin et al., 2017) and were maintained as
heterozygous stocks over a 3rd chromosome balancer. The stocks were reared on standard
Drosophila medium containing corn meal, yeast, and sucrose at 23˚C under 12hr light/dark
cycles.
WT and Aggregate Specific Antibodies
Rabbit anti-dsod1 polyclonal antibodies were synthesized at Pacific Immunology. The antibodies
were isolated, purified, resuspended in saline, after rabbits were inoculated with synthesized
peptide sequences: CMSSGPHFNPYGKEHG for antibody 56-71, SIIGRTVVVHADADDL for
antibody 111-126, and ADADDLGQGGHELSKSTGNAGAR for antibody 120-142. The
respective antibodies were affinity purified from crude serum, resuspended in saline, and stored
at -20 as frozen aliquots.
Immunohistochemistry
Drosophila tissues were dissected in 1x PBS and fixed in 3.4% formaldehyde (Salivary glands =
25 min; adult brains and VNC = 30 mins) at room temperature. Samples were quickly washed
three times in PBTx (1x PBS + 0.1% Triton-X) and then three 15-min washes. Samples were
incubated in 5% normal goat serum in PBTx for at least 2 hours before being incubated in
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primary antibody over-night (see figure captions for concentrations). Prior to use, the primary
antibodies were pre-absorbed against tissue from dsod1null flies for 24 hrs to increase specificity.
Following incubations with primary antibody, tissues were washed quickly three times in PBTx
before three 15-min washes and incubated in secondary antibody AlexaFluor 488 or 649 (see
figure captions for concentrations). Samples were washed quickly three times in PBTx before
three 15-min washes and stained with DAPI in 1x PBS (1:1000). Three quick 1x PBS washes
were conducted and samples were mounted in diamond mount. Slides were kept at 4 ˚C before
imaging.
Confocal Microscopy and Quantification of Fluorescence Using ImageJ
Images were taken on an Olympus Fluoview 1000, utilizing an IX81 inverted confocal
microscope. All fluorescent signals were captured within the linear detection range for
quantification purposes. Imaging processing was performed in ImageJ (FIJI) and consisted of
optimizing brightness and contrast for publication. Fluorescent signals were quantified using the
Analyze à Set Measurements tab of ImageJ. Briefly, the region of interest (ROI) was designated
using the ellipse tool and the integrated signal density of each ROI was determined using the
Analyze à Measure function within ImageJ. Three measurements were taken for the cytoplasm
and nucleus of cells. Three measurements were taken for the background, which is area outside
of the sample, and the average was used to correct the background. The corrected total cell
fluorescence, CTCF, was calculated for each measurement (equation based on Vlab Amrita Edu.,
2012). In this equation, the area of the circle was multiplied by the mean gray value of the
background and the product was subtracted from the integrated density of the cytoplasmic or
nuclear measurements to obtain CTCF values. CTCF values were averaged for the cytoplasmic
and nuclear measurements of each sample for each larval line.
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ImageJ was used to collect vacuole lengths by using the line tool and measuring their
lengths. The longest length within ten vacuoles for each sample were measured on ImageJ and
further quantified on excel by averaging the ten measurements. ImageJ was also used to count
the number of aggregates in an image. Images were converted to 16-bit and the pixel intensity
threshold range was set to 65-65535. At this range, only aggregates were detected. Once applied,
Process à Binary à Watershed unmerged any particles. Analyze à Analyze Particles produced
the number of particles detected.
Excel was used for statistics and graphs for all quantitative data collected using ImageJ.
Compounds
Mifepristone (Cayman Chemicals) was dissolved in DMSO.
Enhancer Screen
A genetic enhancer screen was conducted as described previously (Betancur, 2019). To
knockdown gene expression of ebp1 in sodG85R heterozygotes, males from line 34388 (y[1] sc[*]
v[1] sev[21]; P{y[+t7.7] v[+1.8]=TRiP.HMS01382}attP2) obtained from the Bloomington Stock
Center (https://bdsc.indiana.edu) were crossed to w-; tubulin-geneswitch Gal4, sod1G85R/Tm6Tb
virgin females in standard fly food medium that contained 3µg/mL of mifepristone in 0.4%
DMSO. After 7 days, adults were removed and wandering non-tubby larvae were collected for
dissections.
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RESULTS
A common characteristic among ALS-causing genes such as SOD1 is the presence of
protein aggregates. To investigate the role of aggregates in ALS, we studied tissue samples from
a Drosophila melanogaster model of ALS created by homologous recombination. Mutant
Drosophila sod1 (dsod1) show recessive phenotypes including shortened lifespan, progressive
axon loss and locomotion defects in contrast to the human disease state. We wanted to determine
if short-lived phenotypes correlated with SOD1 protein aggregation. Using aggregate specific
antibodies, we used immunohistochemical techniques to detect puncta. We used salivary glands
because of their large cell size and pharate adult ventral nerve cords as a region of the CNS
containing motor neuron cell populations.
Assessing SOD1 aggregation using the 56-71 aggregate-specific antibody
To visualize aggregation status of dSOD1 protein, we stained salivary glands from
dsod1+/+, dsod1H48R/H48R, and dsod1G85R/G85R wandering larvae using the aggregate specific 56-71
antibody. This antibody specifically recognizes a hidden epitope on the native dSOD1 protein
and therefore, fluorescent signals suggests misfolding protein. To first determine specificity of
the antibody, we stained dsod1-/- animals which represent SOD1 protein nulls as controls. A
representative single slice confocal image for dsod1-/- is shown in Fig. 1A. Here, we detected
modest nuclear and cytoplasmic fluorescence which was quantified in Fig. 1B. This is
attributable to background fluorescence or non-specific antibody binding. In contrast, salivary
glands from wildtype animals displayed qualitatively higher nuclear staining that was
comparable with the dsod1G85R/G85R mutants (Fig. 1A and 1B). dsod1H48R/H48R salivary gland
staining showed lower nuclear dSOD1 levels than nulls (Fig. 1B). dsod1H48R/H48R salivary glands
also displayed large and scattered cytoplasmic aggregates with partial penetrance (Fig. 1A and
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Table 1). Aggregates are identified qualitatively as bright, localized punctae and represent a
standard method for identifying aggregates (Gill et al., 2018). Large dSOD1-positive
cytoplasmic aggregates were also detected near the nuclei of dsod1G85R/G85R samples at low
penetrance (white arrows) (Fig. 1A; Table 1). Therefore, wandering dsod1H48R/H48R and
dsod1G85R/G85R salivary glands display slightly different mutant-specific phenotypes with partial
penetrance.
Assessing SOD1 aggregation using the aggregate specific antibody 111-126
To further characterize dSOD1 aggregates, we stained salivary gland tissue with the other
dSOD1 aggregate-specific antibody 111-126, which putatively recognizes a separate epitope that
is mostly hidden in native dSOD1. We stained wandering dsod1-/-, dsod1+/+, and dsod1H48R/H48R
salivary glands and representative images are shown in Fig. 2. The dsod1-/- negative control
glands displayed similar background to dsod1+/+; however, salivary glands from dsod1H48R/H48R
displayed a modest increase in nuclear and cytoplasmic staining compared to dsod1-/-. When
present, most punctae in dsod1H48R/H48R salivary gland samples were small (~1-5 microns) though
a small subset of samples displayed the large cytoplasmic aggregates as shown in dsod1H48R/H48R
of approximately 5-10 microns as shown sample (B). These punctae were clearly distinct from
any staining observed in null controls or wildtype (Fig. 2A and Table 1). This antibody revealed
similar staining to that observed with the 56-71 antibody for dsod1H48R/H48R. Also, the
dsod1H48R/H48R (B) sample displayed nuclear staining levels lower than what was observed in
nulls (Fig. 2B). Together these results provide confidence that both antibodies identify as least
some aggregate conformations. To quantify the number of aggregates across all lines, we used
ImageJ software to detect aggregates over a specific pixel intensity threshold. We found the
dsod1H48R/H48R (B) mutant samples showed binary aggregation status. Samples either had many
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punctae (almost 2x more inclusions), or more commonly, we found dsod1H48R/H48R glands with
relatively fewer inclusions (Fig. 2C). Therefore, wandering dsod1H48R/H48R salivary glands display
a mutant-specific phenotype that was detected using two different aggregate-specific antibodies
but with partial penetrance. This suggests a mutant-specific phenotype in which misfolded
dsod1H48R/H48R is prone to aggregation in some individuals more than others.
Time course analysis of dsod1H48R/H48R and dsod1G85R/G85R salivary glands
The fact that aggregation was not fully penetrant despite controlling for genotype was an
intriguing finding. One possibility was that aggregation (seen most prominently in
dsod1H48R/H48R) could be developmentally regulated and thus partial penetrance resulted from
slightly different stages being used for each experiment. Salivary glands are larval specific
tissues which undergo histolysis during the early stages of metamorphosis (Farkaš et al., 2015).
Salivary gland cells undergo apoptotic and autophagic cell death in response to increased titers in
the hormone 20-hydroxyecdysone in the absence of juvenile hormone. During histolysis, these
cells undergo a number of molecular and morphology changes. To determine if dSOD1 protein
localization and/or aggregation changes during development, we stained salivary glands
dissected from animals over a time-course that spans the early stages of metamorphosis. While
we observed no striking differences in phenotypes in mutants compared to wildtype for salivary
glands of third-instar or wandering larvae, we found striking differences in salivary glands of
mutant sod animals during the prepupal stages (Fig. 3). Specifically, we found that staining of
dsod1+/+ and dsod1H48R/H48R salivary glands at pre-pupation with either of the aggregate specific
antibodies resulted in coagulated dSOD1 under high magnification (Fig. 3). While we observed
nuclear staining in dsod1+/+ at pre-pupation, generally, most samples displayed slightly more

28

nuclear staining in dsod1H48R/H48R nuclei (not shown). This observation was true using both
antibodies.
We took the time course analysis a step further by analyzing dSOD1 staining using the
111-126 aggregate-specific antibody on dsod1-/-, dsod1+/+, dsod1G85R/G85R, and dsod1H48R/H48R
salivary glands at pre-pupation and 8 hours post-pupation (Fig. 4). All lines at pre-pupation
showed irregularly shaped cells and small cellular vacuoles likely linked to the initial stages of
histolysis (Fig. 4A). Generally, null samples had the greatest number of smaller vacuoles when
compared to the other lines (Fig. 4A). When comparing the pre-pupation and 8 hours postpupation salivary glands, the 8-hour samples were thinner than the pre-pupation samples (Fig.
4A and 4B). Mutant dsod1H48R/H48R generally had more nuclear staining and nuclear envelope
staining when compared to null and wildtype at pre-pupation (Fig. 4A). We observed that mutant
lines generally looked comparable to wildtype at 8 hours post-pupation (Fig. 4B). Some 8 hours
post-pupation samples from these lines displayed large vacuoles (Fig. 5A). The longest length
from 10 vacuoles were analyzed using ImageJ tools and the lengths were averaged on excel. The
null sample had the largest average length vacuoles compared to the wildtype, dsod1G85R/G85R,
and dsod1H48R/H48R salivary glands (Fig. 5B). The dsod1G85R/G85R sample had the smallest average
vacuole length when compared to the other lines.
Assessing aggregation in adult VNCs
ALS is an adult-onset, neurodegenerative disease and therefore, it is important to
characterize dSOD1 protein staining in the Drosophila nervous system. To further characterize
dSOD1 protein staining in adult nervous tissue, we collected the ventral nerve cords (VNCs) of
dsod1-/-, dsod1+/+, dsod1G85R/G85R, and dsod1H48R/H48R pharate adults (Fig. 7). We stained the
VNCs with aggregate specific antibody 56-71 and visualized the results by confocal microscopy.
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We found that both dsod1G85R/G85R and dsod1H48R/H48R VNCs displayed mutant-specific
differences when compared to wildtype and null. Mutant dsod1G85R/G85R VNC displayed dense
staining at high magnification compared to dsod1-/- and dsod1+/+ samples. The dsod1H48R/H48R
VNC at high magnification displayed colocalization of dSOD1-positive aggregates with large
nuclei. These large nuclei are consistent with motor neurons or glia though we never verified
this. We saw that this colocalization in this specific area was observed in lower layers of the
VNC (not shown). Similar to salivary glands, we observed this aggregation in a minority of
cases. Therefore, VNC mutants display an aggregation phenotype in adult CNS with partial
penetrance.
Quantifying the partial penetrance of aggregation phenotypes.
As mentioned, immunohistochemistry of salivary glands revealed that while some mutant
samples were comparable with null and wildtype, other samples displayed striking mutantspecific cellular puncta. To quantify the percentage of glands containing these aggregates, we
tallied samples containing large cytoplasmic aggregates. We kept track of the total number of
samples for each dsod1 line under a specific antibody. For each line and antibody used, we
divided the number of samples that had aggregates over the total for that subset. We found that
no large cytoplasmic aggregates were found in dsod1+/+ salivary glands (Table 1). We also found
that for dsod1G85R/G85R and dsod1H48R/H48R samples, the large cytoplasmic aggregates phenotype
was partially penetrant (<16%) for all aggregate-specific antibodies (Table 1).
Enhancing effects of Ebp1 knockdown in a heterozygous dsod1G85R background
Our previous research showed that knockdown of ErbB3-binding protein-1 (ebp1) caused
selective lethality in dsod1G84R/+ heterozygotes compared to dsod1+/+ animals (Betancur, 2019).
To determine whether knockdown of ebp1 knockdown affects SOD1 protein aggregation or

30

localization, we stained salivary glands from dsod1G85R/+ heterozygotes with and without
knockdown of ebp1. Knockdown of ebp1 expression was achieved using dicer-mediated RNA
interference (RNAi). A mifepristone (MIF)-sensitive Gal4 was used to drive expression of the
UAS-RNAi construct, resulting in presumptive knockdown of ebp1 in the presence of MIF.
Larvae were fed MIF in the food medium during development and we stained salivary glands
from wandering larvae across genotypes in 3 ug/mL MIF food versus controls containing 0 MIF.
Salivary glands were stained with aggregate-specific 56-71 and visualized by confocal
microscopy (Fig. 8A). At 0μL/mL MIF, dSOD1 expression was comparable between all the lines
(Fig. 8A and 8B). At 3µL/mL, the ebp1RNAi;dsod1G85R/+ salivary gland was much thinner in width
compared to 0µL/mL treatments. Under ebp1 knockdown conditions, the average nuclear and
cytoplasmic CTCFs were also higher for dSOD1 staining compared to 0 ul/mL MIF treatments
(Fig. 8A and 8B). Thus, knockdown of ebp1 results in higher levels of misfolded SOD1 using
the aggregate specific 56-71 antibody. Interestingly, while overall signal was increased, we
found an absence of large punctae as described previously. Furthermore, the knockdown of ebp1
in dsod1G85R/+ heterozygotes resulted in smaller salivary glands, though it is unknown if this is
due to knock down of ebp1 alone. Future experiments will test the 56-71 antibody on the salivary
glands of ebp1RNAi;dsod1+/+ to see if small glands are observed or if there is increased misfolded
dSOD1 detected. Antibody staining data from dsod1-/- and dsod1G85R/+ at 3µL/mL should be also
be included.

DISCUSSION
In the present study, we analyzed SOD1 protein expression using antibody staining in
SOD1 null, wildtype, and mutant tissues of a Drosophila ALS-model expressing dsod1 at
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endogenous levels. We used conformationally-specific antibodies to detect dSOD1 in the cells of
salivary glands, VNCs, and adult brains. Based on known SOD1 misfolding conformations in
mammalian species, these antibodies recognize domains which are inaccessible for properly
folded wildtype SOD1. It is unknown if the folding dynamics of SOD1 are the same in both
Drosophila and the well characterized mouse models. Using antibodies 56-71 and 111-126, we
detected SOD1 aggregation in dsod1G85R/G85R and dsod1H48R/H48R salivary glands at partial
penetrance. Therefore, conformation-specific antibodies detected dsod1 mutant-allele-specific
phenotypes in a Drosophila ALS model. Aggregates were also observed in VNCs with partial
penetrance. Furthermore, as a previously identified enhancer of lethality, knockdown of ebp1
induced dramatic morphological changes in salivary glands and increased amount of misfolded
dSOD1.
Aggregate-specific antibodies were engineered to detect misfolded dSOD1
Bergh and colleagues (2015) engineered SOD1 antibodies that recognized specific amino
acid sequences on humanized SOD1. From this study, one antibody (56-71) recognized a
conformationally hidden region that was detected by immunostaining with misfolded mutant
hSOD1. Another epitope on the SOD1 protein correlates with a partially exposed on the native
structure (111-126), and therefore can also be used to detect misfolded SOD1. These two regions
inspired us to create similar antibodies that can detect misfolded conformations of Drosophila
SOD1.
Aggregate-specific antibodies detects mutant-specific phenotypes
Aggregates are a common phenotype in fALS (Johnston et al., 2000; Gruzman et al.,
2007). We wanted to test our aggregate-specific antibodies in the salivary glands and VNCs of
Drosophila expressing mutant alleles to reported molecular differences between control and
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mutant lines, and more importantly, assess the presence of dSOD1-positive aggregates. While all
dsod1-/- samples exhibited high background when using both antibodies, dsod1+/+,
dsod1G85R/G85R, and dsod1H48R/H48R samples generally exhibited enhanced staining in the nucleus
and cytoplasm and we observed the presence of puntae, inferred to be aggregated protein. The
fact that high background could be sometimes observed in sodnull, could be due to insufficient
washing during the immunohistochemical protocol, incomplete blocking, or non-optimized
antibody concentrations. One focus of future experiments should be to optimize the
immunohistochemical procedure.
We found that both aggregate-specific antibodies detected the same mutant-specific
phenotypes with partial penetrance in dsod1G85R/G85R and dsod1H48R/H48R salivary glands (Fig. 1,
Fig 2, and Table 1). dsod1G85R/G85R salivary glands displayed large cytoplasmic aggregates near
the nucleus of cells, a phenotype not seen in wildtype samples (Fig.1 and Table 1). This may
suggest that mutant dsod1G85R/G85R follows a pathological pathway leading to its interaction with
structures near the nucleus, such as the endoplasmic reticulum (ER). Research suggests SOD1
colocalizes to the ER under ER stress (Atkin et al., 2014; Medinas et al., 2018). It is possible that
the ER fails to properly fold mutant dsod1G85R/G85R and the protein becomes stuck within the
structure. Further directions should determine how to induce this phenotype and determine
whether there is colocalization between dsod1G85R/G85R protein and the ER in salivary glands.
We also observed large cytoplasmic aggregates in dsod1H48R/H48R salivary glands with
partial penetrance using both aggregate specific antibodies (Fig. 2 and Table 1). This phenotype
was not observed in null or wildtype samples (Table 1). The amount of aggregates observed in
the dsod1H48R/H48R sample far exceeded the amount found in the other dsod1 lines (Fig. 2B).
Although most dsod1H48R/H48R salivary glands did not display this striking feature, the partial
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penetrance of this phenotype suggests that dsod1H48R/H48R protein can induce the formation of
large aggregates. Large dsod1-positive aggregates were detected in each cell of the salivary
gland which also suggests that misfolded dsod1H48R/H48R has the prion-like property of
propagating aggregation. It is possible that the aggregates arose in one cell and spread, or it is
possible that the aggregates arose in every cell independently. Further experiments should
explore what factors induce this phenotype and why it is specific to dsod1H48R/H48R salivary
glands.
Adult dsod1H48R/H48R flies also displayed a mutant-specific phenotype in the CNS.
Interestingly, large nuclei colocalized with dsod1-positive aggregates in the VNCs of
dsod1H48R/H48R pharate adults (Fig. 7). This phenotype was not observed in null or wildtype
VNCs. It is unusual for aggregates to colocalize in the nucleus, but research suggests that SOD1
can migrate to the nucleus under oxidative stress as a nuclear transcription factor (Tsang et al.,
2014).
The ability to recapitulate aggregation in neuronal and non-neuronal tissues of a mutant
Drosophila ALS model is an important observation and suggests the Drosophila knock-in model
shares much overlap with mammalian overexpression models.
From our study, we detected aggregates with partial penetrance. While only a fraction of
samples analyzed showed aggregate formation, there is still 100% lethality for dsod1G85R/G85R and
dsod1H48R/H48R. This result suggests that there is not a complete correlation between the presence
of large, insoluble cytoplasmic aggregates and lethality. Based on studies in mammalian models,
large dSOD1 aggregates are catalytically inactive (Martins & English, 2014) and are the product
of the accumulation of aberrantly behaved dSOD1 protein. Our antibodies may be detecting
small, misfolded mutant dSOD1 that is too small to be detected using confocal microscopy or
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aggregates which are still soluble. For a number of misfolded proteins, intermediate forms are
highly reactive, have greater toxicity, and can induce misfolding of more protein to create higher
order structures (Elam et al., 2003; Rakhit et al., 2004; Khare et al., 2004; McAlary et al., 2016).
Therefore, if we are limited to detecting large aggregates using these antibodies, we may miss
dSOD1 soluble intermediates responsible for disease lethality.
Time course analysis and salivary gland histolysis
Due to the appearance of mutant-specific phenotypes, we conducted salivary gland time
course analyses to determine whether the phenotypes were age-dependent. We believe the
partially penetrant mutant phenotypes are not age-dependent because no result suggested the
appearance of aggregates prior to histological events. Evidence of the large cytoplasmic
aggregates present in dsod1G85R/G85R or dsod1H48R/H48R salivary glands from figures 1 or 2 were
not detected throughout the time course analysis. Therefore, other factors such as cellular stress
may be involved in the development of the mutant-specific phenotypes of dsod1G85R/G85R and
dsod1H48R/H48R salivary glands.
Ebp1 knockdown enhanced heterozygous dsod1G85R/+ disease phenotypes
ErbB3-binding protein 1 (ebp1) is a known enhancer of lethality in heterozygous
dsod1G85R/+ larvae. Ebp1 is an RNA-bind protein involved in growth regulation, ribosome
assembly, and rRNA processing (NCBI, 2020). Most ebp1 information comes from cancer
research because of its involvement in the cell cycle (Hwang et al., 2016; Nguyen et al., 2016).
Knockdown of epb1 alone in Drosophila larvae development followed Mendelian patterns of
inheritance (refer to Betancur, 2019). Our results showed that when ebp1 is knocked down in the
heterozygous dsod1G85R/+ background, we observed reduced salivary gland width when
compared to controls and increased misfolded dSOD1 in the nucleus and cytoplasm of cells. We
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did not stain epb1RNAi;dsod1+/+ salivary glands to determine whether the knockdown of ebp1
alone results in reduced salivary gland size. Ebp1-/- expressing mice were ~30% smaller than the
wildtype stains (Zhang et al., 2008). Due to the role of ebp1 in the cell cycle, it makes sense that
a common phenotype of ebp1 knockdown is reduce animal size. Moreover, one study suggested
that decreased expression of a cell cycle regulated protein in SOD1G85R mutant cells induced
DNA damage and decreased viability (Wang et al., 2019). Therefore, irregularities in the
involvement of ebp1 in growth regulation may result in cellular stress, which produced increased
misfolded SOD1. Further testing is needed to recapitulate the results of the ebp1 enhancer screen
and to determine how epb1 knockdown enhances heterozygous dsod1G85R/+ misfolding.
ALS is a complex disease with various components that come together to induce
pathological phenotypes. The present study has revealed mutant-specific phenotypes that may
explain possible pathways involved in SOD1-ALS pathology. Although my research contributes
few findings, these results can be built upon to further characterize protein expression of specific
dsod1 disease-alleles in cells. The results can be correlated to the human disease to generate new
therapeutics and treatments.
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Figure 1. Aggregate-specific antibody 56-71 detected large cytoplasmic aggregates in
dsod1G85R/G85R and dsod1H48R/H48R salivary glands at partial penetrance. dSOD1 aggregates
are localized around the nucleus in dsod1G85R/G85R samples with partial penetrance (white arrows)
and diffuse large cytoplasmic aggregates were detected in dsod1H48R/H48R samples also with
partial penetrance. A. Single slice images of wandering dsod1-/-, dsod1+/+, dsod1H48R/H48R, and
dsod1G85R/G85R larvae salivary glands stained with the aggregate specific 56-71 antibody at 1:300
(except dsod1H48R/H48R which was stained at 1:100). DAPI (1:1000); AlexaFluor 647 (1:400). B.
Average CTCF quantifications for the cytoplasm and nucleus of each line for all samples except
dsod1G85R (B). Error bars represent standard error.
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Figure 2. Aggregate-specific antibody 111-126 detected large cytoplasmic aggregates in
dsod1H48R/H48R salivary glands at partial penetrance. A. Single slice confocal images of
wandering dsod1-/-, dsod1+/+, and dsod1H48R/H48R larvae salivary glands stained with the
aggregate-specific 111-126 antibody at 1:500. DAPI (1:1000); AlexaFluor 647 (1:400). B.
Average CTCF for the cytoplasm and nucleus of each line. Bars represent standard error. C. The
number of inclusions detected over a specific pixel intensity threshold (see methods). Error bars
represent standard error.
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Figure 3. dSOD1 shows stage-specific aggregation. Time course analysis of dsod1+/+ and
dsod1H48R/H48R salivary glands at third instar, wandering, and pre-pupation stages stained with
two aggregate specific antibodies. Salivary glands were incubated in aggregate-specific
antibodies at concentrations ranging from 1:100 to 1:300. Single slice confocal images were
processed using ImageJ software. DAPI (1:1000); AlexaFluor 647 (1:400). 3rd = third-instar; W
= wandering; PP = pre-pupation.
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Figure 4. Mutant salivary glands are morphologically comparable to wildtype samples 8
hours post-pupation. Time course analysis of dsod1-/-, dsod1+/+, dsod1G85R/G85R, and
dsod1H48R/H48R salivary glands at pre-pupation or 8 hours post-pupation stages. Salivary glands
were incubated in the aggregate-specific antibody 111-126 at 1:300. DAPI (1:1000); AlexaFluor
647 (1:400). Single slice confocal images were processed using ImageJ software is presented. A.
Pre-pupation stage. B. 8 hours post-pupation.
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Figure 5. dsod1-/- had the largest vacuoles and dsod1G85R/G85R had the shortest compared to
all other lines. A. Single slice confocal images of highly vacuolized dsod1-/-, dsod1+/+,
dsod1G85R/G85R, and dsod1H48R/H48R salivary glands 8 hours post-pupation were incubated in the
aggregate-specific 111-126 antibody at 1:300. All images were processed using ImageJ. DAPI
(1:1000); AlexaFluor 647 (1:400). B. Average length of vacuoles. The longest length of ten
vacuoles in each sample was measured using ImageJ and all measurements were averaged on
excel. Error bars represent standard error.
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Figure 6. dsod1G85R/G85R, and dsod1H48R/H48R VNCs display mutant-specific differences
compared to null and wildtype. Ventral nerve cords (VNC) of dsod1H48R/H48R pharate adults
displayed large aggregates that colocalized with large nuclei, and the dsod1G85R/G85R had dense
staining compared to null and wildtype. VNCs of dsod1-/-, dsod1+/+, dsod1G85R/G85R, and
dsod1H48R/H48R pharate adults were incubated in the aggregate-specific 56-71 antibody. dsod1-/and dsod1G85R/G85R 56-71 staining was at 1:1000; dsod1+/+and dsod1H48R/H48R 56-71 staining was
at 1:500. DAPI (1:1000); AlexaFluor 647 (1:800). Single slice confocal images were corrected
on ImageJ.
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Figure 7. Preliminary data suggests ebp1 knockdown increases dSOD1 selectively in
dsod1G85R/+ heterozygotes. A. Wandering stage larvae salivary glands of dsod1-/-, dsod1G85R/+,
and ebp1RNAi;dsod1G85R/+ reared on fly food containing 0 μL/mL or 3μL/mL of MIF were
collected and incubated in aggregate-specific antibody 56-71 at 1:300. Single slice confocal
images were analyzed using ImageJ. DAPI (1:1000); AlexaFluor 647 (1:400). B. Average CTCF
for nuclear and cytoplasmic dSOD1 staining for each dsod1 line. Error bars represent standard
error.
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Table 1. Partial penetrance of mutant dsod1G85R/G85R and dsod1H48R/H48R phenotype among a
collection of individual confocal images.
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